EUVIMEDEUVIMED entdecken
Kohortenstudie

Clinical and biochemical spectrum of APOB-related hypobetalipoproteinemia: Insights from a retrospective cohort study

İlknur Sürücü Kara, Engin Köse, Hatice Mutlu, Aslıhan Sanrı, Patrizia Tarugi, Fatma Tuba Eminoğlu

Journal of Clinical Lipidology · 2025

DOI: 10.1016/j.jacl.2025.02.003 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Lipidology, 2025. Verfasst von İlknur Sürücü Kara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Metabolism, Ankara University Faculty of Medicine, Ankara, Turkey (Dr Kara). Hauptthemen laut MEDLINE: Hypobetalipoproteinemia, Familial, Apolipoprotein B, Apolipoproteins B, Apolipoprotein B-100. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: APOB-related familial hypobetalipoproteinemia (APOB-FHBL), the most common form of primary hypobetalipoproteinemia, often leaves heterozygous patients asymptomatic. This study aims to provide updated insights into the complications observed in heterozygous and homozygous APOB-FHBL patients. METHODS: A retrospective analysis was conducted on 15 patients (53.3% female) from 7 families diagnosed with FHBL and followed in a metabolic clinic. Demographic, laboratory, clinical, and genetic data were reviewed. RESULTS: Patients were followed for an average of 4.5 ± 4.1 years. The median levels were as follows: low-density lipoprotein cholesterol (LDL-C; 25.7 ± 10.5 mg/dL), apolipoprotein B (ApoB; 0.3 ± 0.1 g/L), aspartate aminotransferase (AST; 40.1 ± 22.5 U/L), alanine aminotransferase (ALT; 43.0 ± 38.3 U/L), and alpha feto-protein (1.3 ± 0.7 ng/mL). Elevated AST and ALT levels were observed in 20.0% and 26.7% of cases, respectively. Vitamin E deficiency was identified in 26.7%, vitamin A deficiency in 13.3%, and vitamin D insufficiency in 66.7% of cases. Liver ultrasonography revealed hepatosteatosis in 73.3% of patients. Additionally, the study identified 5 novel APOB gene variants. Among the families, 3 had members who died due to complications related to viral infections (COVID-19, hepatitis B virus) or hepatocellular carcinoma (HCC) resulting from chronic liver disease. CONCLUSION: Patients with elevated transaminase levels or hepatosteatosis should undergo a lipid profile assessment. LDL-C levels below 50 mg/dL require further evaluation, including ApoB and fat-soluble vitamin levels. Monoallelic APOB variants are linked to poor outcomes due to deficiencies in vitamins A, E, and D, as well as an increased risk of HCC. Early recognition and regular monitoring are essential for the effective management of APOB-FHBL patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypobetalipoproteinemia, Familial, Apolipoprotein BApolipoproteins BApolipoprotein B-100HumansFemaleMaleRetrospective StudiesAdultMiddle AgedAlanine TransaminaseCholesterol, LDLAspartate Aminotransferases

Stichwörter der Autor:innen

Elevated transaminasesHepatosteatosisHypobetalipoproteinemia

Substanzen

Apolipoproteins BAlanine TransaminaseAPOB protein, humanCholesterol, LDLApolipoprotein B-100Aspartate Aminotransferases

Autor:innen und Institutionen

  • Department of Pediatric Metabolism, Ankara University Faculty of Medicine, Ankara, Turkey (Dr Kara).
  • Department of Pediatric Metabolism, Ankara University Faculty of Medicine, Ankara, Turkey (Dr Kara); Ankara University Rare Diseases Application and Research Center, Ankara, Turkey (Drs Köse, Eminoğlu). Electronic addre…
  • Departments of Pediatric Genetics, Faculty of Medicine, Ankara University, Ankara, Turkey (Dr Mutlu).
  • Department of Pediatric Genetics, Samsun Education and Research Hospital, Samsun, Turkey (Dr Sanrı).
  • Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy (Dr Tarugi).
  • Department of Pediatric Metabolism, Ankara University Faculty of Medicine, Ankara, Turkey (Dr Kara); Ankara University Rare Diseases Application and Research Center, Ankara, Turkey (Drs Köse, Eminoğlu).

Zitieren

APA

Sürücü Kara, İ., Köse, E., Mutlu, H., Sanrı, A., Tarugi, P., & Eminoğlu, F. T. (2025). Clinical and biochemical spectrum of APOB-related hypobetalipoproteinemia: Insights from a retrospective cohort study. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2025.02.003

Vancouver

Sürücü Kara İ, Köse E, Mutlu H, Sanrı A, Tarugi P, Eminoğlu FT. Clinical and biochemical spectrum of APOB-related hypobetalipoproteinemia: Insights from a retrospective cohort study. Journal of Clinical Lipidology. 2025. doi:10.1016/j.jacl.2025.02.003

BibTeX
@article{SrcKara2025,
  author = {Sürücü Kara, İlknur and Köse, Engin and Mutlu, Hatice and Sanrı, Aslıhan and Tarugi, Patrizia and Eminoğlu, Fatma Tuba},
  title = {Clinical and biochemical spectrum of APOB-related hypobetalipoproteinemia: Insights from a retrospective cohort study},
  journal = {Journal of Clinical Lipidology},
  year = {2025},
  doi = {10.1016/j.jacl.2025.02.003}
}
Kostenlos starten →